Pluribus Labs’s Emcor EME Stock Holding History

Pluribus Labs’s Portfolio EME Stock Details EME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-5,841	Closed	-$744K	–	114
2021 Q4	$744K	Buy	+5,841	New	+$723K	0.78%	15

Other funds holding EME

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pluribus Labs's EME Position: Q1 2022 in Review

Pluribus Labs sold out of Emcor (EME) in Q1 2022, closing a stake of 5,841 shares — an estimated $744K sold.

Pluribus Labs first reported a position in EME in Q4 2021 and held it in 1 quarter. The position peaked at $744K in Q4 2021. 394 funds tracked by Wall St. Rank hold EME as of Q1 2022.

Pluribus Labs reported no remaining Emcor position as of Q1 2022 after selling out during the quarter.
Pluribus Labs sold 5,841 Emcor shares in Q1 2022, an estimated $744K.
Pluribus Labs first reported a position in Emcor in Q4 2021 and held it in 1 quarter.
Pluribus Labs's Emcor position peaked at $744K in Q4 2021.
394 funds tracked by Wall St. Rank held Emcor as of Q1 2022.

Based on Pluribus Labs's 13F filing for Q1 2022, filed 16 May 2022.